124 related articles for article (PubMed ID: 38510482)
1. SUV39H1-driven NFATc1 methylation is essential for the c-Cbl-mediated degradation of NFATc1 in an osteoclast lineage.
Jeong DW; Kim HJ; Park JW; Lee S; Jung H; Yi EC; Kim N; Chun YS
Genes Dis; 2024 Jul; 11(4):101034. PubMed ID: 38510482
[No Abstract] [Full Text] [Related]
2. Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1.
Kim JH; Kim K; Jin HM; Song I; Youn BU; Lee SH; Choi Y; Kim N
J Biol Chem; 2010 Feb; 285(8):5224-31. PubMed ID: 20037154
[TBL] [Abstract][Full Text] [Related]
3. Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation.
Li X; Wei W; Huynh H; Zuo H; Wang X; Wan Y
Elife; 2015 Jul; 4():e07217. PubMed ID: 26173181
[TBL] [Abstract][Full Text] [Related]
4. PTPRJ promotes osteoclast maturation and activity by inhibiting Cbl-mediated ubiquitination of NFATc1 in late osteoclastogenesis.
Shalev M; Arman E; Stein M; Cohen-Sharir Y; Brumfeld V; Kapishnikov S; Royal I; Tuckermann J; Elson A
FEBS J; 2021 Aug; 288(15):4702-4723. PubMed ID: 33605542
[TBL] [Abstract][Full Text] [Related]
5. Regulation of NFATc1 in Osteoclast Differentiation.
Kim JH; Kim N
J Bone Metab; 2014 Nov; 21(4):233-41. PubMed ID: 25489571
[TBL] [Abstract][Full Text] [Related]
6. ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.
Jeong BC; Kim JH; Kim K; Kim I; Seong S; Kim N
Bone; 2017 Feb; 95():33-40. PubMed ID: 27829167
[TBL] [Abstract][Full Text] [Related]
7. KBTBD11, a novel BTB-Kelch protein, is a negative regulator of osteoclastogenesis through controlling Cullin3-mediated ubiquitination of NFATc1.
Narahara S; Sakai E; Kadowaki T; Yamaguchi Y; Narahara H; Okamoto K; Asahina I; Tsukuba T
Sci Rep; 2019 Mar; 9(1):3523. PubMed ID: 30837587
[TBL] [Abstract][Full Text] [Related]
8. MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR.
Kim JH; Kim K; Youn BU; Jin HM; Kim N
Cell Signal; 2010 Sep; 22(9):1341-9. PubMed ID: 20466061
[TBL] [Abstract][Full Text] [Related]
9. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation.
Nishikawa K; Nakashima T; Hayashi M; Fukunaga T; Kato S; Kodama T; Takahashi S; Calame K; Takayanagi H
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3117-22. PubMed ID: 20133620
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast.
He L; Lee J; Jang JH; Sakchaisri K; Hwang J; Cha-Molstad HJ; Kim KA; Ryoo IJ; Lee HG; Kim SO; Soung NK; Lee KS; Kwon YT; Erikson RL; Ahn JS; Kim BY
Cell Signal; 2013 Feb; 25(2):552-60. PubMed ID: 23178987
[TBL] [Abstract][Full Text] [Related]
11. ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function.
Zou W; Izawa T; Rohatgi N; Zou SY; Li Y; Teitelbaum SL
JBMR Plus; 2022 Apr; 6(4):e10613. PubMed ID: 35434449
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N
J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714
[TBL] [Abstract][Full Text] [Related]
13. Essentiality of Nfatc1 short isoform in osteoclast differentiation and its self-regulation.
Omata Y; Tachibana H; Aizaki Y; Mimura T; Sato K
Sci Rep; 2023 Nov; 13(1):18797. PubMed ID: 37914750
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizae Radix Inhibits Osteoclast Differentiation by Inhibiting c-Fos-Dependent NFATc1 Expression.
Rho TW; Lee SY; Han SY; Kim JH; Lee KH; Kim DS; Kwak HB; Kim YK
Am J Chin Med; 2017; 45(2):283-298. PubMed ID: 28231743
[TBL] [Abstract][Full Text] [Related]
15. The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption.
Charles JF; Coury F; Sulyanto R; Sitara D; Wu J; Brady N; Tsang K; Sigrist K; Tollefsen DM; He L; Storm D; Aliprantis AO
Bone; 2012 Nov; 51(5):902-12. PubMed ID: 22985540
[TBL] [Abstract][Full Text] [Related]
16. Wogonin inhibits osteoclast differentiation by inhibiting NFATc1 translocation into the nucleus.
Geng X; Yang L; Zhang C; Qin H; Liang Q
Exp Ther Med; 2015 Sep; 10(3):1066-1070. PubMed ID: 26622440
[TBL] [Abstract][Full Text] [Related]
17. JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation.
Youn MY; Yokoyama A; Fujiyama-Nakamura S; Ohtake F; Minehata K; Yasuda H; Suzuki T; Kato S; Imai Y
J Biol Chem; 2012 Apr; 287(16):12994-3004. PubMed ID: 22375008
[TBL] [Abstract][Full Text] [Related]
18. Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor.
Kim K; Lee J; Kim JH; Jin HM; Zhou B; Lee SY; Kim N
J Immunol; 2007 May; 178(9):5588-94. PubMed ID: 17442941
[TBL] [Abstract][Full Text] [Related]
19. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis.
Asagiri M; Sato K; Usami T; Ochi S; Nishina H; Yoshida H; Morita I; Wagner EF; Mak TW; Serfling E; Takayanagi H
J Exp Med; 2005 Nov; 202(9):1261-9. PubMed ID: 16275763
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.
Song I; Kim JH; Kim K; Jin HM; Youn BU; Kim N
FEBS Lett; 2009 Jul; 583(14):2435-40. PubMed ID: 19576893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
